PPA
CTMX icon

Parametric Portfolio Associates’s CytomX Therapeutics CTMX Stock Holding History

Parametric Portfolio Associates’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$65K Sell
24,371
-17,390
-42% -$66.8K ﹤0.01% 3608
2021
Q4 		$181K Buy
41,761
+353
+0.9% +$2.07K ﹤0.01% 3444
2021
Q3 		$211K Buy
41,408
+2,209
+6% +$11.8K ﹤0.01% 3416
2021
Q2 		$248K Sell
39,199
-20,621
-34% -$161K ﹤0.01% 3330
2021
Q1 		$462K Sell
59,820
-38,841
-39% -$307K ﹤0.01% 3535
2020
Q4 		$646K Sell
98,661
-121,471
-55% -$868K ﹤0.01% 3253
2020
Q3 		$1.46M Sell
220,132
-31,343
-12% -$232K ﹤0.01% 2686
2020
Q2 		$2.1M Buy
+251,475
New +$2.34M ﹤0.01% 2477

Other funds holding CTMX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return